Klinik Atölye

Lenfatik sistem ve dalak · Kavram · Orta öncelik

Lenf nodu ölçümü ve morfolojik değerlendirme

Lymph node measurement and morphology

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez.

Lenf nodu ölçümü ve morfolojik değerlendirme: yayımlanmış olgu görüntüsü, aksiyel kesit
Görüntü konuyu kısmen gösteriyor; bulgunun bir bölümü seçilebilir.

4 adım

Görüntü: Han AY, Lentz JF, Kuan EC ve ark., “A Case of Reactive Cervical Lymphadenopathy with Fat Necrosis Impinging on Adjacent Vascular Structures.” 2016, Figure 1. PMC5093268 · doi:10.1155/2016/6019501 · CC BY 4.0. Değişiklik: yeniden boyutlandırıldı.

Özet

Lenf nodlarını doğru ölçmek, hem olası hastalık yükünü tanımlamak hem de zaman içindeki değişimi karşılaştırmak için gerekir. BT'de kısa eksen, nodun uzun eksenine dik ölçülür; ancak tek bir çap eşiği bütün istasyonlar ve tümörler için malignite tanısı koydurmaz. RECIST kriterleri onkolojik çalışmalarda tedavi yanıtını değerlendirmek için standarttır; lenf nodu metastazının tanısında ise görüntülenen nodların boyutu yanında morfolojik değerlendirme de kullanılır. Lenf nodlarının doğru tanımlanması evreleme açısından önemlidir; BT’de boyut ve morfolojiye dayalı ölçütlerin tanısal doğruluğu sınırlı olabilir.

Faz ve pencere

Portal tanısal
BT’de lenf nodu boyutu kısa eksen çapıyla değerlendirilir.

Önerilen pencereler: Batın (G 400 / M 50), Mediasten (G 350 / M 50), Yumuşak doku (G 400 / M 40).

BT bulguları

  • Ölçüm çizgisi nodun gerçek uzun eksenine dik olmalı; eğik aksiyel kesitte koronal veya sagittal rekonstrüksiyon daha doğru kısa ekseni gösterebilir.
  • Aynı istasyondaki nodları damar kesiti, bağırsak duvarı, gonad veya peritoneal implanttan ayırmak için çok düzlemli devamlılık ve anatomik komşuluk izlenir.
  • Lenf nodunun yuvarlaklaşması, düzensiz kenarları ve nod dışına uzanımı gibi morfolojik değişiklikler maligniteyi düşündürür; ancak boyut kriterlerinin tek başına tanısal değeri sınırlıdır ve morfolojik özellikler ayırıcı tanıda destekleyici rol oynar.
  • İstasyon adı anatomik haritayla verilir: örneğin sol paraaortik, sağ alt paratrakeal, subkarinal veya obturator zincir.
  • Seri incelemede aynı nodun aynı anatomik istasyondaki kısa ekseni, aynı rekonstrüksiyon kalınlığı ve benzer düzlemde kıyaslanır.
  • Kontrastsız toraks BT’de nodal kalsifikasyon veya büyük damarlardan yüksek atenüasyon benignite lehine bir görüntüleme ipucu olarak tanımlanmıştır; morfolojik BT ölçütlerinin tanısal doğruluğu sınırlıdır.

Ölçütler ve sınıflamalar

RECIST 1.1 patolojik nod eşiği
kısa eksen ≥10 mm
RECIST 1.1 ölçülebilir hedef nod
RECIST değerlendirmesinde lenf nodları kısa eksenlerinden ölçülür.
RECIST 1.1 patolojik olmayan nod
kısa eksen <10 mm

Normalde

Lenf nodlarının BT değerlendirmesinde kısa eksen çapı ve morfolojik özellikler dikkate alınır. Aynı kesitte nodun kısa eksen çizgisini, uzun eksene dik olacak biçimde yerleştir ve önceki incelemede aynı damar dalları ile vertebra düzeyine göre eşleştir.

Normal BT ile kıyasla

Aynı bölgenin, kaynak veri setinde patoloji içermediği belirtilen bir BT incelemesini kesit kesit kaydırın; organ sınırlarını açarak anatomiyi hasta görüntüsüyle karşılaştırın. Küçük rastlantısal bulgular tümüyle dışlanmamıştır.

Kaynak: TotalSegmentator v2.01 veri seti (Wasserthal ve ark., Radiology: Artificial Intelligence 2023), CC BY 4.0, vaka s0119; organ sınırları veri setinin otomatik segmentasyonundan, birleştirilerek sadeleştirildi. Görüntüler 2,5 mm kesit aralığına yeniden örneklendi.

Ayırıcı tanı

Toraks BT'de damarlar ile hiler ve mediastinal lenf nodları anatomik olarak yakın bulunur; kontrastsız görüntülerde nodda kalsifikasyon veya büyük damarlara göre daha yüksek atenüasyon benign hastalık lehine yorumlanabilir.
İnce bağırsak ansı değerlendirilirken ilişkili lenfadenopati de göz önünde bulundurulmalıdır.
Peritoneal implant
bağırsak serozası ya da periton yüzeyine oturur, nodal zincir boyunca beklenen yerleşimi izlemez.
Postoperatif lenfosel, cerrahi sonrası görülebilen bir komplikasyondur.

Tuzaklar

  • Lenf nodu boyut değerlendirmesinde kısa eksen çapı kullanılır; kısa ve uzun eksen oranı da morfolojik değerlendirmeye katılabilir.
  • RECIST sınırlarını her anatomik bölge için evrensel malignite sınırı gibi kullanma; tümör türüne ve istasyona özgü ölçütler değişebilir.
  • Nazofarenks kanserinde, kısa ekseni 10 mm’den küçük küçük lenf nodlarında okült mikrometastaz bulunabilir; boyut tek başına metastazı dışlamaz.

Kendini dene

  1. Onkolojik çalışmalarda lenf nodu ve tümör yanıtının izlenmesinde kullanılan standart ölçüt setinin adı nedir?

    Cevabı göster

    RECIST. RECIST (Response Evaluation Criteria in Solid Tumors), onkolojik çalışmalarda tedavi yanıtını değerlendirmek için standart olarak kullanılır.

  2. RECIST değerlendirmesinde lenf nodu için hangi çap ölçülür?

    Cevabı göster

    Kısa eksen çapı. RECIST değerlendirmesinde lenf nodları kısa eksenlerinden ölçülür.

İlgili konular

Kaynaklar

Bu sayfadaki 32 cümle ve 2 quiz sorusu aşağıdaki kaynaklardan alıntılarla otomatik olarak karşılaştırıldı; 19 cümle bu karşılaştırmada düzeltildi (2026-10-09).

  1. Is surgical lymph node assessment justified for ground glass opacity-dominant lung adenocarcinoma?pmc.ncbi.nlm.nih.gov
  2. Correlation of the Diagnostic Accuracy of Dual Energy Computed Tomography and Positron Emission Tomography/Computed Tomography in Mediastinal Lymph Node Staging in Lung Cancer: A Systematic Reviewpmc.ncbi.nlm.nih.gov
  3. Nodal metastasis from an occult duodenal gastrinoma amid an overlap of xanthogranulomatous and type 1 autoimmune pancreatitis: A case reportpmc.ncbi.nlm.nih.gov
  4. The value of dual-energy computed tomography quantitative parameters in differentiating the sensitivity of small lymph nodes to chemoradiotherapy in nasopharyngeal carcinomapmc.ncbi.nlm.nih.gov
  5. Pre-contrast computed tomography reveals distinct characteristics and anatomical distribution of presumably lymphomatous lymph nodes in canine multicentric lymphomapmc.ncbi.nlm.nih.gov
  6. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).pubmed.ncbi.nlm.nih.gov
  7. Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis.pubmed.ncbi.nlm.nih.gov
  8. Mediastinal incidentalomas.pubmed.ncbi.nlm.nih.gov
  9. Journal club: The pediatric appendix: defining normal.pubmed.ncbi.nlm.nih.gov
  10. PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.pubmed.ncbi.nlm.nih.gov
  11. Radiologic Assessment of Groin Lymph Nodes in Pelvic Malignancies.pubmed.ncbi.nlm.nih.gov
  12. Sinus histiocytosis with massive lymphadenopathy Rosai-Dorfman disease: a unique case presentation.pubmed.ncbi.nlm.nih.gov
  13. Dual-energy CT in the differentiation of stage T1 nasopharyngeal carcinoma and lymphoid hyperplasia.pubmed.ncbi.nlm.nih.gov
  14. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.pubmed.ncbi.nlm.nih.gov
  15. Benign regional lymph nodes in gastric cancer on multidetector row CT.pubmed.ncbi.nlm.nih.gov
  16. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.pubmed.ncbi.nlm.nih.gov
  17. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.pubmed.ncbi.nlm.nih.gov
  18. Application of Dual-Energy Spectral Computed Tomography to Thoracic Oncology Imaging.pubmed.ncbi.nlm.nih.gov
  19. Paracicatricial melanocytes as a sign of melanoma.pubmed.ncbi.nlm.nih.gov
  20. Spleens With Disseminated Lymphoma Exhibit Higher Standardized Uptake Value Maximum, Metabolic Tumor Volumes, and Total Lesion Glycolysis on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.pubmed.ncbi.nlm.nih.gov
  21. Diagnostic Efficacy of Clinico-Pathological Parameters in Predicting Nodal Positivity in Oral Cavity Squamous Cell Carcinoma: A Multivariate Risk Assessment.pubmed.ncbi.nlm.nih.gov
  22. Clinical Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) on Staging, Biochemical Recurrence Detection, and Treatment Decision-Making in Prostate Cancer.pubmed.ncbi.nlm.nih.gov
  23. Differentiating pulmonary sarcoidosis from mediastinal lymph node metastasis via conventional computed tomography features and quantitative imaging parameters: a retrospective study.pubmed.ncbi.nlm.nih.gov
  24. Preoperative ultrasound risk stratification of submandibular gland lesions: a retrospective cohort study.pubmed.ncbi.nlm.nih.gov
  25. High-resolution ultrasound imaging of the spinal accessory nerve and associated injuries based on a prospective normative study and retrospective analysis.pubmed.ncbi.nlm.nih.gov
  26. Assessing the reliability of Response Evaluation Criteria In Solid Tumors (RECIST): a systematic review of the factors contributing to inter-observer variability.pubmed.ncbi.nlm.nih.gov
  27. Contrast-enhanced mammography in the setting of neoadjuvant therapy from a multidisciplinary perspective.pubmed.ncbi.nlm.nih.gov
  28. Medical imaging in immunotherapy response evaluation: from RECIST to AI-driven longitudinal models, and the distinction between risk prediction and kinetic diagnosis.pubmed.ncbi.nlm.nih.gov
  29. Malignant lymph nodes of the head and neck: imaging pearls, pitfalls, and practical approach to reporting in the era of extranodal extension.pubmed.ncbi.nlm.nih.gov
  30. The Atypical and Suspicious for Malignancy Categories of the WHO Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Review of their Diagnostic Utility, Limitations, and Clinical Impact.pubmed.ncbi.nlm.nih.gov
  31. HPV-associated Oropharyngeal Squamous Cell Carcinoma: An Imaging Framework for AJCC Version 9 TNM Staging.pubmed.ncbi.nlm.nih.gov
  32. Nodal staging.pubmed.ncbi.nlm.nih.gov
  33. Patterns of injury and violence in Yaoundé Cameroon: an analysis of hospital data.pubmed.ncbi.nlm.nih.gov
  34. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer.pubmed.ncbi.nlm.nih.gov
  35. International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.pubmed.ncbi.nlm.nih.gov
  36. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.pubmed.ncbi.nlm.nih.gov
  37. Current status and future trends of real-time imaging in gastric cancer surgery: A literature review.pubmed.ncbi.nlm.nih.gov
  38. Special Issue: EACR 2026 Congress: Innovative Cancer Science, 8-11 June 2026.pubmed.ncbi.nlm.nih.gov
  39. Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer-A Systematic Review and Meta-analysis.pubmed.ncbi.nlm.nih.gov
  40. Carotid artery stenosis and ischemic cerebrovascular events after radiotherapy in patients with head and neck cancer.pubmed.ncbi.nlm.nih.gov
  41. Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers.pubmed.ncbi.nlm.nih.gov
  42. Fluid transport in the brain.pubmed.ncbi.nlm.nih.gov
  43. Correlation of the Diagnostic Accuracy of Dual Energy Computed Tomography and Positron Emission Tomography/Computed Tomography in Mediastinal Lymph Node Staging in Lung Cancer: A Systematic Review.pubmed.ncbi.nlm.nih.gov
  44. Conventional chest CT features are associated with Ki-67 labeling index in lung adenocarcinoma: a single-center retrospective radiopathologic study.pubmed.ncbi.nlm.nih.gov
  45. Determinants of single‑pass specimen adequacy in endobronchial ultrasound-guided transbronchial needle aspiration: a real-world study.pubmed.ncbi.nlm.nih.gov
  46. Deep Learning Quality Control for RECIST-Oriented Assessment: A Vision Transformer Predicts Inter-Reader Variability of Unidimensional Lesion Measurements on Contrast CT.pubmed.ncbi.nlm.nih.gov
  47. Pretreatment prognostic nutritional index and immune status for response to preoperative neoadjuvant chemotherapy in cervical squamous cell carcinoma: an exploratory retrospective study.pubmed.ncbi.nlm.nih.gov
  48. Multiparametric MRI Assessment of Cervical Lymphadenopathy: Combined Diagnostic Performance of Morphological Features and Apparent Diffusion Coefficient.pubmed.ncbi.nlm.nih.gov
  49. Current Status and Challenges of Imaging-Based Diagnosis of Lymph Node Metastasis in Colon Cancer: The Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.pubmed.ncbi.nlm.nih.gov
  50. Solid Primary Retroperitoneal Masses in Adults: An Imaging Approach.pubmed.ncbi.nlm.nih.gov
  51. Celiac ganglia: can they be misinterpreted on multimodal 68Ga-PSMA-11 PET/MR?pubmed.ncbi.nlm.nih.gov
  52. Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus.pubmed.ncbi.nlm.nih.gov
  53. 2.5-mm articulated endoluminal forceps using a compliant mechanism.pubmed.ncbi.nlm.nih.gov
  54. Genicular Artery Embolization for Osteoarthritis Related Knee Pain: A Systematic Review and Qualitative Analysis of Clinical Outcomes.pubmed.ncbi.nlm.nih.gov
  55. Correlating Ultrastructural Changes in the Invasion Area of Colorectal Cancer with CT and MRI Imaging.pubmed.ncbi.nlm.nih.gov
  56. From Magnetic Moment to Magnetic Particle Imaging: A Comprehensive Review on MPI Technology, Tracer Design and Biological Applications.pubmed.ncbi.nlm.nih.gov
  57. Human biomarker navigator.pubmed.ncbi.nlm.nih.gov
  58. International Society of Paediatric Surgical Oncology (IPSO) Minimally Invasive Surgery (MIS) Guidelines.pubmed.ncbi.nlm.nih.gov
  59. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).pubmed.ncbi.nlm.nih.gov
  60. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).pubmed.ncbi.nlm.nih.gov
  61. Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging.pubmed.ncbi.nlm.nih.gov
  62. Does laparoscopic surgery decrease the risk of atrial fibrillation after foregut surgery?pubmed.ncbi.nlm.nih.gov
  63. Percutaneous sclerotherapy of cystic lesions.pubmed.ncbi.nlm.nih.gov
  64. High-affinity alphavbeta3 integrin targeted optical probe as a new imaging biomarker for early atherosclerosis: initial studies in Watanabe rabbits.pubmed.ncbi.nlm.nih.gov
  65. Long-term safety and effectiveness of the "OptEase" vena cava filter.pubmed.ncbi.nlm.nih.gov
  66. Commentary: an eye on PET quantification.pubmed.ncbi.nlm.nih.gov
  67. Pelvic neurovascular anatomy and avascular spaces: a pictorial essay of key surgical landmarks.pubmed.ncbi.nlm.nih.gov
  68. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update.pubmed.ncbi.nlm.nih.gov
  69. EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025.pubmed.ncbi.nlm.nih.gov
  70. Chinese expert consensus on imaging examination and diagnosis of nasal cavity and paranasal sinus tumors.pubmed.ncbi.nlm.nih.gov
  71. Pheochromocytomas and Paragangliomas-Current Management.pubmed.ncbi.nlm.nih.gov
  72. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.pubmed.ncbi.nlm.nih.gov
  73. WiNGPT-32B: An Open-Source, Locally Deployable LLM for RECIST Assessment via Chained Task Execution Using Radiology Report Text.pubmed.ncbi.nlm.nih.gov
  74. SFRT alleviates symptoms associated with bulky advanced cancer: a retrospective single-center cohort analysis.pubmed.ncbi.nlm.nih.gov
  75. Carbon nanoparticle-Fe (II) complex for ferroptosis therapy in refractory solid tumors: a phase I trial.pubmed.ncbi.nlm.nih.gov
  76. Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer.pubmed.ncbi.nlm.nih.gov
  77. Machine Learning Meets Cancer.pubmed.ncbi.nlm.nih.gov
  78. Diagnostic Potential of Apparent Diffusion Coefficient-Based Lymph Node Classification in Breast Cancer Patients Undergoing [<sup>18</sup>F]FDG-PET/MRI.pubmed.ncbi.nlm.nih.gov
  79. Lymph Node Assessment with Multiparametric Ultrasound: Normal Values, Morphologic Patterns, and Diagnostic Algorithms.pubmed.ncbi.nlm.nih.gov
  80. ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases.pubmed.ncbi.nlm.nih.gov
  81. DICOM structured reporting and cancer clinical trials results.pubmed.ncbi.nlm.nih.gov
  82. A dynamic nomogram for predicting axillary pathological complete response and its prognostic value in HER2-positive breast cancer.pubmed.ncbi.nlm.nih.gov
  83. Investigating the optimal timing for the ultrasound prediction of a pathologic complete response in neoadjuvant breast cancer treatment.pubmed.ncbi.nlm.nih.gov
  84. Is surgical lymph node assessment justified for ground glass opacity-dominant lung adenocarcinoma?pubmed.ncbi.nlm.nih.gov
  85. Seeing Angiogenesis: Multiparametric Ultrasound as a Non-Invasive Window into the Vascularization Status of Cervical Lymph Nodes in Head and Neck Squamous Cell Carcinoma.pubmed.ncbi.nlm.nih.gov
  86. CT-Derived Radiomic Features for the Non-Invasive Differentiation of Mediastinal Lymphadenopathy in Lung Cancer and Sarcoidosis.pubmed.ncbi.nlm.nih.gov
  87. Diagnostic performance of whole-body diffusion-weighted imaging for staging esophageal cancer: a comparative study with PET-CT.pubmed.ncbi.nlm.nih.gov
  88. Efficacy and limitations of diffusion-weighted imaging with background suppression-based whole-body magnetic resonance imaging in high-risk prostate cancer staging: A retrospective study.pubmed.ncbi.nlm.nih.gov
  89. PET Imaging in Vulvar Cancer: A Literature Review of the Current Evidence and Clinical Applications.pubmed.ncbi.nlm.nih.gov
  90. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.pubmed.ncbi.nlm.nih.gov
  91. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.pubmed.ncbi.nlm.nih.gov
  92. Computed tomographic Characteristics of Presumed Normal Canine Iliosacral Lymph Nodes.pubmed.ncbi.nlm.nih.gov
  93. Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure.pubmed.ncbi.nlm.nih.gov
  94. Practice guidelines for managing extrahepatic biliary tract cancers.pubmed.ncbi.nlm.nih.gov
  95. Ileal tuberculosis presenting with severe unexplained anemia and unusual pseudo-tumoral imaging features: A case report.pubmed.ncbi.nlm.nih.gov
  96. CT and MR in peritoneal malignancies: pearls and pitfalls at preoperative examination.pubmed.ncbi.nlm.nih.gov
  97. Small Intestine Tumors: Diagnostic Role of Multiparametric Ultrasound.pubmed.ncbi.nlm.nih.gov
  98. Tubal Cancer Clinical Management: Two Exceptional Scenarios and a Review of the Literature.pubmed.ncbi.nlm.nih.gov
  99. Diffusion-Weighted Magnetic Resonance Imaging in Ovarian Cancer: Exploiting Strengths and Understanding Limitations.pubmed.ncbi.nlm.nih.gov
  100. Approach to Cystic Lesions in the Abdomen and Pelvis, with Radiologic-Pathologic Correlation.pubmed.ncbi.nlm.nih.gov
  101. Multidetector CT imaging of post-robot-assisted laparoscopic radical prostatectomy complications.pubmed.ncbi.nlm.nih.gov
  102. Consistency and efficiency of CT analysis of metastatic disease: semiautomated lesion management application within a PACS.pubmed.ncbi.nlm.nih.gov
  103. Diagnostic Performance of Ultrasonography Compared to Cross-Sectional Imaging in Thyroid-Related Nodal Metastasis: A Retrospective Cohort Study from Saudi Arabia.pubmed.ncbi.nlm.nih.gov
  104. Application and Development of Spectral CT in Target Delineation for Lung Cancer Radiotherapy.pubmed.ncbi.nlm.nih.gov
  105. Insects as hosts for mutualistic bacteria.pubmed.ncbi.nlm.nih.gov
  106. Rethinking Common Diagnoses: Idiopathic Multicentric Castleman Disease Presenting as TAFRO Syndrome: A Case Report.pubmed.ncbi.nlm.nih.gov
  107. Diagnostic delay and histopathological subtyping challenges in idiopathic multicentric Castleman disease, not otherwise specified: a case report of a three-hospital odyssey.pubmed.ncbi.nlm.nih.gov
  108. Case Report: Successful conversion of gallbladder cancer with intrahepatic metastases using camrelizumab combined with gemcitabine and cisplatin.pubmed.ncbi.nlm.nih.gov
  109. Lymphatic Endothelial Cells in Health and Disease.pubmed.ncbi.nlm.nih.gov
  110. Evaluating Performance of Transvaginal Doppler Parameters in Differentiating Cervical Neoplastic Severity.pubmed.ncbi.nlm.nih.gov
  111. Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent.pubmed.ncbi.nlm.nih.gov
  112. Lymphedema imaging and AI: A review of diagnostic modalities, biomarkers, and clinical integration.pubmed.ncbi.nlm.nih.gov
  113. Review of Non-Invasive Imaging Technologies for Cutaneous Melanoma.pubmed.ncbi.nlm.nih.gov
  114. Analysis of the clinicopathological characteristics of pulmonary sclerosing pneumocytoma (PSP).pubmed.ncbi.nlm.nih.gov
  115. Congenital pulmonary airway malformation mimicking lung cancer in adults: a pitfall in oncologic diagnosis.pubmed.ncbi.nlm.nih.gov

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez, tıbbi tavsiye değildir. Metinler yapay zekâ desteğiyle yazıldı ve otomatik bir adımda kaynak alıntılarıyla karşılaştırıldı; bu bir tıbbi doğrulama değildir ve içerik uzman radyolog incelemesinden geçmedi. Klinik kararlarda güncel kılavuzları, kurum protokollerini ve radyoloji raporunu esas alın.